Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication

被引:37
|
作者
Srinivas, RV
Ray, RB
Meyer, K
Ray, R
机构
[1] ST LOUIS UNIV, HLTH SCI CTR, DIV INFECT DIS & IMMUNOL, ST LOUIS, MO 63110 USA
[2] ST JUDE CHILDRENS RES HOSP, DIV INFECT DIS, MEMPHIS, TN 38105 USA
[3] ST LOUIS UNIV, INST MOL VIROL, ST LOUIS, MO 63110 USA
关键词
long terminal repeat; hepatitis C virus; human immunodeficiency virus;
D O I
10.1016/S0168-1702(96)01361-5
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We previously demonstrated that hepatitis C virus (HCV) core protein is a strong repressor of human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR) basal transcription. In this study, we have localized the HCV core protein-response domain to a region between nucleotides -65 and +3 within the HIV-LTR. Thus, neither the upstream negative regulatory elements, or binding sites for various transcription factors (e.g. NF-kappa B, USF-1, IL2/IL-2R) nor the downstream TAR regions were involved in HCV core-mediated repression. HCV core protein mediated repression of the basal transcriptional activity of HIV-1 LTR was abrogated by the Tat protein. Furthermore, HeLa-T4 cells expressing HCV core protein showed inhibition of HIV-1 replication after acute infection with cell-free HIV. A similar observation was also noted in CD4(+) and CD4(-) lymphocytic cell lines cotransfected with an infectious molecular clone of HIV-1 and the HCV core protein expression vector. Thus, a repression of basal transcription prior to the accumulation of threshold levels of Tat protein appears to restrict HIV-1 transcription and modulate viral replication.
引用
收藏
页码:87 / 92
页数:6
相关论文
共 50 条
  • [31] Herpes simplex virus infection induces replication of human immunodeficiency virus type 1
    Moriuchi, M
    Moriuchi, H
    Williams, R
    Straus, SE
    [J]. VIROLOGY, 2000, 278 (02) : 534 - 540
  • [32] Human SMOOTHENED inhibits human immunodeficiency virus type 1 infection
    Yoshida, Takeshi
    Hamano, Akiko
    Ueda, Asuka
    Takeuchi, Hiroaki
    Yamaoka, Shoji
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 493 (01) : 132 - 138
  • [33] Management of the coinfected patient: Human immunodeficiency virus/hepatitis B and human immunodeficiency virus/hepatitis C
    Murphy, MJ
    Wilcox, RD
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2004, 328 (01): : 26 - 36
  • [34] Tritherapy for human immunodeficiency virus infection does not modify replication of hepatitis C virus in coinfected subjects
    Zylberberg, H
    Chaix, ML
    Rabian, C
    Rouzioux, C
    Aulong, B
    Bréchot, C
    Viard, JP
    Pol, S
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 26 (05) : 1104 - 1106
  • [35] Treatment with PTEN-Long protein inhibits hepatitis C virus replication
    Wu, Qi
    Li, Zhubing
    Liu, Qiang
    [J]. VIROLOGY, 2017, 511 : 1 - 8
  • [36] Association of Nef with the human immunodeficiency virus type 1 core
    Kotov, A
    Zhou, J
    Flicker, P
    Aiken, C
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (10) : 8824 - 8830
  • [37] NITAZOXANIDE INHIBITS HEPATITIS C VIRUS REPLICATION IN VITRO
    Schaninger, Takako
    Hong, Junghee
    Luo, Guangxiang G.
    [J]. HEPATOLOGY, 2008, 48 (04) : 756A - 756A
  • [38] Caffeine inhibits hepatitis C virus replication in vitro
    Mariana N. Batista
    Bruno M. Carneiro
    Ana Cláudia S. Braga
    Paula Rahal
    [J]. Archives of Virology, 2015, 160 : 399 - 407
  • [39] Raloxifene inhibits hepatitis C virus infection and replication
    Takeda, Midori
    Ikeda, Masanori
    Mori, Kyoko
    Yano, Masahiko
    Ariumi, Yasuo
    Dansako, Hiromichi
    Wakita, Takaji
    Kato, Nobuyuki
    [J]. FEBS OPEN BIO, 2012, 2 : 279 - 283
  • [40] Caffeine inhibits hepatitis C virus replication in vitro
    Batista, Mariana N.
    Carneiro, Bruno M.
    Braga, Ana Claudia S.
    Rahal, Paula
    [J]. ARCHIVES OF VIROLOGY, 2015, 160 (02) : 399 - 407